Boston Scientific Corp. Stock Slides 5.1%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Boston Scientific Corp. slid 5.1% to $49.37 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.9% to 7,641.16 and Dow Jones Industrial Average falling 1.3% to 52,759.21.

Boston Scientific Corp. closed 54.9% short of its 52-week high of $109.50, which the company reached on September 9th.

The stock underperformed when compared to some of its peers, as Abbott Laboratories fell 0.3% to $114.14, Medtronic PLC fell 1.9% to $92.30, and Stryker Corp. fell 3.61% to $327.70.

Trading volume totaled 20.4 million, compared to the 50-day average of 19.6 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 20, 2026 16:34 ET (20:34 GMT)